OncoImmune, Inc.

Biotechnology company · Rockville, Maryland, United States

OncoImmune, Inc. is a biotechnology company headquartered in Rockville, Maryland, United States. It has received 9 US government small-business research awards (SBIR/STTR) from health agencies, $7 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2020.

www.oncoimmune.comProfile compiled from public records. Is this your company? Request a correction or update

OncoImmune at a glance

Typebiotechnology company

HeadquartersRockville, Maryland, United States

Employees (self-reported, 2020)8

SEC CIK1695528

What does OncoImmune do?

US government research funding

9 SBIR/STTR small-business research awards from US health agencies, $7 million in total (2011 to 2020). NIH funding came from the National Cancer Institute, National Heart, Lung, and Blood Institute, OD.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $3 million sold (2020).

Frequently asked questions about OncoImmune

Where is OncoImmune headquartered?

OncoImmune, Inc. is headquartered in Rockville, Maryland, United States.

What does OncoImmune do?

OncoImmune, Inc. is a biotechnology company.

Similar companies

REGENXBIO Inc.Rockville, Maryland, United States
Immunomic Therapeutics, Inc.Rockville, Maryland, United States
OncoC4, Inc.Rockville, Maryland, United States
Integrated Biotherapeutics LLCRockville, Maryland, United States
Sanaria Inc.Rockville, Maryland, United States
CASI Pharmaceuticals, Inc (DE)Rockville, Maryland, United States
Rise Therapeutics, LLCRockville, Maryland, United States
KinaRx, Inc.Rockville, Maryland, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences